Back to top

medical-devices: Archive

Zacks Equity Research

Butterfly Network (BFLY) Unveils iQ+ Bladder Ultrasound Scanner

Butterfly Network (BFLY) uses proprietary Ultrasound-on-Chip technology to streamline the bladder scanning process.

DVANegative Net Change ALGNNegative Net Change MEDPNegative Net Change BFLYNegative Net Change

Zacks Equity Research

Three Reasons to Retain AMN Healthcare (AMN) Stock for Now

Investors remain optimistic about AMN Healthcare's (AMN) broad array of services.

ECLNegative Net Change DVANegative Net Change AMNNegative Net Change VEEVNegative Net Change

Zacks Equity Research

HealthEquity (HQY) Closes Conduent's BenefitWallet Acquisition

HealthEquity (HQY) completes the acquisition of Conduent's BenefitWallet HSA portfolio. This is likely to further strengthen the HSA business of HealthEquity.

BSXPositive Net Change ECLNegative Net Change ALGNNegative Net Change HQYPositive Net Change

Zacks Equity Research

Labcorp (LH) to Assess Preeclampsia Risk With New Test

Labcorp's (LH) new first-trimester test is the latest addition to its dedication to improving women's health.

LHNegative Net Change RMDNegative Net Change MEDPNegative Net Change EHCNegative Net Change

Zacks Equity Research

Profound Medical (PROF) Adds AI to Prostate Cancer Treatment

Profound Medical's (PROF) Contouring Assistant integrates AI into prostate cancer procedures, thereby streamlining the treatment planning process and enhancing both efficiency and precision.

DVANegative Net Change ALGNNegative Net Change MEDPNegative Net Change PROFNegative Net Change

Zacks Equity Research

Thermo Fisher (TMO) Unveils New Extended Blood Genotyping Array

Thermo Fisher's (TMO) new Applied Biosystems Axiom BloodGenomiX Array and Software provide a high-throughput solution for more precise blood matching research.

TMONegative Net Change MEDPNegative Net Change HIMSPositive Net Change HITINo Net Change

Zacks Equity Research

Here's Why Investors Should Retain QIAGEN (QGEN) Stock Now

QIAGEN's (QGEN) solid potential in the NGS platform buoys optimism for investors.

QGENPositive Net Change MEDPNegative Net Change HIMSPositive Net Change HITINo Net Change

Zacks Equity Research

Here's Why You Should Retain Henry Schein (HSIC) Stock for Now

Investors are optimistic about Henry Schein (HSIC), owing to strategic acquisitions and potential in Henry Schein One.

RMDNegative Net Change HSICNegative Net Change MEDPNegative Net Change EHCNegative Net Change

Zacks Equity Research

Merit Medical (MMSI) to Expand Product Suite Via New Launch

Merit Medical's (MMSI) latest additions to its embolotherapy portfolio are likely to improve the patient experience.

ECLNegative Net Change DVANegative Net Change MMSINegative Net Change VEEVNegative Net Change

Zacks Equity Research

Reasons to Add Veeva Systems (VEEV) Stock to Your Portfolio

Veeva System's (VEEV) strong product demand and strategic deals raise optimism about the stock.

BSXPositive Net Change ECLNegative Net Change ALGNNegative Net Change VEEVNegative Net Change

Zacks Equity Research

GE HealthCare (GEHC), Medis Medical Partner to Aid CAD Therapy

GE HealthCare (GEHC) and Medis Medical collaborate to boost precision care for coronary artery disease treatment.

BSXPositive Net Change ECLNegative Net Change ALGNNegative Net Change GEHCNegative Net Change

Zacks Equity Research

Here's Why You Should Buy Align Technology (ALGN) Stock Now

Investors are optimistic about Align Technology (ALGN) led by expansion in new geographies and upbeat guidance.

ALGNNegative Net Change RMDNegative Net Change MEDPNegative Net Change EHCNegative Net Change

Zacks Equity Research

QIAGEN's (QGEN) QCI Interpret Gets European IVDR Certification

QIAGEN's (QGEN) Clinical Insight Interpret is the first NGS interpretation platform approved by IVDR for use in cancer and hereditary applications.

RMDNegative Net Change QGENPositive Net Change MEDPNegative Net Change EHCNegative Net Change

Urmimala Biswas

3 Solid Buys From MedTech Following 2024 Guidance Raise

Guidance hikes by BSX, ALGN and ALC for 2024 make them attractive investment bets.

BSXPositive Net Change ALGNNegative Net Change ALCNegative Net Change

Zacks Equity Research

Henry Schein (HSIC) Extends Partnership With Special Olympics

Henry Schein's (HSIC) extended collaboration with Special Olympics is likely to promote wellness and health education for athletes with ID around the world.

RMDNegative Net Change HSICNegative Net Change HIMSPositive Net Change HITINo Net Change

Zacks Equity Research

Here's Why You Should Retain Zimmer Biomet (ZBH) Stock for Now

Strong procedure recovery and progress on the four-pillar strategy bode well for Zimmer Biomet (ZBH).

ZBHPositive Net Change MEDPNegative Net Change HIMSPositive Net Change HITINo Net Change

Zacks Equity Research

Senseonics' (SENS) Deal With Mercy to Drive Eversense CGM Sales

Senseonics Holdings (SENS) collaborates with Mercy to bring its Eversense CGM to a healthcare system that is likely to drive its adoption.

DVANegative Net Change ALGNNegative Net Change SENSNegative Net Change MEDPNegative Net Change

Zacks Equity Research

Stereotaxis (STXS) Inks Deal to Buy Access Point Technologies

Stereotaxis' (STXS) deal to acquire electrophysiology catheter developer, Access Point Technologies, is likely to strengthen its position within the catheter market.

DVANegative Net Change ALGNNegative Net Change STXSNo Net Change MEDPNegative Net Change

Zacks Equity Research

Alcon (ALC) Q1 Earnings Surpass Estimates, Margins Expand

Alcon's (ALC) Q1 results reflect substantial growth in its franchises on the back of healthy markets.

RMDNegative Net Change ALCNegative Net Change MEDPNegative Net Change EHCNegative Net Change

Zacks Equity Research

Baxter's (BAX) Clinolipid Gets FDA's Expanded Indication

Baxter's (BAX) receipt of the latest expanded indication for Clinolipid is expected to meet the diverse nutritional needs of patients, ranging from preterm neonates to adults.

ECLNegative Net Change BAXNegative Net Change DVANegative Net Change VEEVNegative Net Change

Zacks Equity Research

Glaukos (GKOS) Reaches 52-Week High: What's Aiding the Stock?

Investors are optimistic about Glaukos' (GKOS) strength in its flagship iStent.

ECLNegative Net Change DVANegative Net Change VEEVNegative Net Change GKOSNegative Net Change

Zacks Equity Research

Philips' (PHG) Gets FDA Recall for Trilogy Ventilator Glitch

Philips' (PHG) software update for Trilogy Evo ventilators is set to mitigate a possible power malfunction and gets FDA Class I recall identification, as it may cause serious harm.

BSXPositive Net Change ECLNegative Net Change PHGPositive Net Change ALGNNegative Net Change

Zacks Equity Research

QIAGEN (QGEN) Wins FDA Nod for QIAstat-Dx Respiratory Panel Plus

QIAGEN (QGEN) receives FDA clearance for the QIAstat-Dx respiratory syndromic testing panel for fast and accurate results.

RMDNegative Net Change QGENPositive Net Change HIMSPositive Net Change HITINo Net Change